BNIP3 has also been applied in a RiskScore model of cholangiocarcinoma, expressing significantly lower in cholangiocarcinoma than normal tissues but higher expression is related to poorer prognosis (Wang Z. et al., 2022), as in BC. This evidence concerns the gene BNIP3 and cholangiocarcinoma.